{"id":17772,"date":"2014-03-12T03:30:00","date_gmt":"2014-03-12T02:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/caso-avastinlucentis-cosa-dicono-le-norme-sull%c2%92uso-degli-off-label-in-italia\/"},"modified":"2014-03-12T03:30:00","modified_gmt":"2014-03-12T02:30:00","slug":"caso-avastinlucentis-cosa-dicono-le-norme-sull%c2%92uso-degli-off-label-in-italia","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/caso-avastinlucentis-cosa-dicono-le-norme-sull%c2%92uso-degli-off-label-in-italia\/","title":{"rendered":"Avastin\/Lucentis case. What the rules on the use of off labels say in Italy"},"content":{"rendered":"<p class=\"MsoNormal\" style=\"text-align: left; line-height: normal; margin: 0cm 0cm 0pt; text-autospace: ; mso-layout-grid-align: none\"><span style=\"font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 12pt\">Italian pharmaceuticals \u2013 largely the &quot;daughter&quot; of multinationals \u2013 is an economic reality: 26 billion in value, 174 factories, 63,500 employees. The newly re-elected president of the association, Scaccabarozzi, is right in saying that the sector is a development lever, not a cost. <\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; line-height: normal; margin: 0cm 0cm 0pt; text-autospace: ; mso-layout-grid-align: none\"><span style=\"font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 12pt\">But the crisis hits: 11,500 fewer jobs (especially informants) in 6 years, they are worrying. Pharmaceuticals are in any case a cost for the state: 14 percent of health expenditure, even if the lowest in Europe and down by 3 percent for six years. To keep up, Farmindustria is asking for less bureaucracy, more efficiency and rapid times for placing new medicines on the market. The same requests as in recent years, in practice, but legitimate for those who have to invest.<\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; line-height: normal; margin: 0cm 0cm 0pt; text-autospace: ; mso-layout-grid-align: none\"><span style=\"font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 12pt\">But they have always remained a dead letter. Why? Perhaps the drug manufacturers are seen as the &quot;rich&quot;, those who exploit people&#039;s need for health? Hard to tell. However the story (recounted by Salute last Tuesday) of the two anticancer drugs produced by Roche and Sanofi, on sale at the expense of citizens for 6,000 and 4,000 euros, certainly does not help the image of the industries.<\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; line-height: normal; margin: 0cm 0cm 0pt; text-autospace: ; mso-layout-grid-align: none\"><span style=\"font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 12pt\">Anti-cancer treatments cannot be a privilege for the few.<\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; line-height: normal; margin: 0cm 0cm 0pt; text-autospace: ; mso-layout-grid-align: none\"><i><span style=\"font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 9pt\"><a href=\"mailto:g.pepe@repubblica.it\"><font color=\"#0523a5\">g.pepe@repubblica.it<\/font><\/a><\/p>\n<p><\/span><\/i><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; line-height: normal; margin: 0cm 0cm 0pt; text-autospace: ; mso-layout-grid-align: none\"><i><span style=\"font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 9pt\">Guglielmo Pepe \u2013 9 July 2013 \u2013 the Republic<\/p>\n<p><\/span><\/i><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; line-height: normal; margin: 0cm 0cm 0pt; text-autospace: ; mso-layout-grid-align: none\"><i><span style=\"font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 9pt\"><\/p>\n<p>&nbsp;<\/p>\n<p><\/span><\/i><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; line-height: normal; margin: 0cm 0cm 0pt; text-autospace: ; mso-layout-grid-align: none\"><strong><span style=\"font-family: &quot;Verdana&quot;,&quot;sans-serif&quot;; color: red; font-size: 14pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial\">Merck Serono: you can believe in Italy<\/span><\/strong><span style=\"font-family: &quot;Georgia&quot;,&quot;serif&quot;; color: #999999; font-size: 10.5pt; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: Arial\"><br \/> <\/span><font size=\"3\"><font face=\"Calibri\">An interview with Stefan Oschmann, worldwide CEO of the German company<span","protected":false},"excerpt":{"rendered":"<p>La farmaceutica italiana &#8211; in larga parte &quot;figlia&quot; delle multinazionali &#8211; &egrave; una realt&agrave; economica: 26 miliardi di valore, 174 fabbriche, 63.500 addetti. Ha ragione il pre sidente dell&#8217;associazione appena rieletto, Scaccabarozzi, nel dire che il settore &egrave; una leva di sviluppo, non un costo. Ma la crisi colpisce: 11.500 posti di lavoro in meno &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-17772","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/17772","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=17772"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/17772\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=17772"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=17772"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=17772"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}